Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTORE: Droxidopa in Neurogenic Orthostatic Hypotension
NCT02586623Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Feb 2016
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of droxidopa in Neurogenic Orthostatic Hypotension (nOH), sponsored by Lundbeck. Started Feb 2016; status: completed.
02
Drugs
droxidopa
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT02586623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586623.